Status of HPV vaccine introduction and barriers to country uptake
2018/03/23 by K.E. Gallagher, Katherine E. Gallagher, D.S. LaMontagne +3 · 28 citations
Medicine · Social Sciences · #Cervical Cancer and HPV Research #Vaccine Coverage and Hesitancy #Hepatitis B Virus Studies
paper · doi:10.1016/j.vaccine.2018.02.003
Abstract
During the last 12 years, over 80 countries have introduced national HPV vaccination programs. The majority of these countries are high or upper-middle income countries. The barriers to HPV vaccine introduction remain greatest in those countries with the highest burden of cervical cancer and the most need for vaccination. Innovation and global leadership is required to increase and sustain introductions in low income and lower-middle income countries.
Cited by
- HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
- Insights on the implementation strategies for a potential new tuberculosis vaccine in South Africa
- Association Between Vaccination for Human Papillomavirus (HPV) and Autonomic Dysfunction and Menstrual Irregularities: A Self-Controlled Case Series Analysis
- Human papillomavirus vaccine delivery in Mozambique: identification of implementation performance drivers using the Consolidated Framework for Implementation Research (CFIR). [europepmc]
- Changes in Cervical Human Papillomavirus (HPV) Prevalence at a Youth Clinic in Stockholm, Sweden, a Decade After the Introduction of the HPV Vaccine. [europepmc]
- Current issues facing the introduction of human papillomavirus vaccine in China and future prospects. [europepmc]
- Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China. [europepmc]
- Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males. [europepmc]
- Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries. [europepmc]
- Knowledge, Attitudes and Perceptions of Immigrant Parents Towards Human Papillomavirus (HPV) Vaccination: A Systematic Review. [europepmc]
- Health systems constraints and facilitators of human papillomavirus immunization programmes in sub-Saharan Africa: a systematic review. [europepmc]
- Editor's Choice: Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. [europepmc]
- National implementation of HPV vaccination programs in low-resource countries: Lessons, challenges, and future prospects. [europepmc]
- HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. [europepmc]
- Cervical Cancer Prevention in Low- and Middle-Income Countries. [europepmc]
- A Framework for Cervical Cancer Elimination in Low-and-Middle-Income Countries: A Scoping Review and Roadmap for Interventions and Research Priorities. [europepmc]
- COVID-19 Vaccination in Lower-Middle Income Countries: National Stakeholder Views on Challenges, Barriers, and Potential Solutions. [europepmc]
- Advancing sustainable development goals through immunization: a literature review. [europepmc]
- Estimate of global human papillomavirus vaccination coverage: analysis of country-level indicators. [europepmc]
- HPV Vaccination: An Underused Strategy for the Prevention of Cancer. [europepmc]
- Challenges and lessons from a school-based human papillomavirus (HPV) vaccination program for adolescent girls in a rural Nigerian community. [europepmc]
- Immunogenicity and safety of one-dose human papillomavirus vaccine compared with two or three doses in Tanzanian girls (DoRIS): an open-label, randomised, non-inferiority trial. [europepmc]
- Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose of HPV vaccine in historical cohorts: an immunobridging analysis of a randomised controlled trial. [europepmc]
- Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. [europepmc]
- Updates on HPV Vaccination. [europepmc]
- Human papillomavirus vaccination in low- and middle-income countries: progression, barriers, and future prospective. [europepmc]
- Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries. [europepmc]
- Comparing one dose of HPV vaccine in girls aged 9-14 years in Tanzania (DoRIS) with one dose in young women aged 15-20 years in Kenya (KEN SHE): an immunobridging analysis of randomised controlled trials. [europepmc]
Related